Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance

NCT00060866 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Neurocardiogenic Syncope

Interventions

DRUG: Propranolol

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)